Allakos Presents Preclinical Data on AK007, a Siglec-10 Antagonist Antibody, at the Society for Immunotherapy of Cancer's 37th Annual Meeting

(marketscreener.com) – Siglec-10 is a myeloid checkpoint receptor selectively expressed on tumor associated macrophages and dendritic cells –– AK007 potently blocks all known ligand interaction with Siglec-10, including the “don’t eat me” signal CD24 –– Monotherapy treatment with a Siglec-10 antagonist antibody polarized...https://www.marketscreener.com/quote/stock/ALLAKOS-INC-44979204/news/Allakos-Presents-Preclinical-Data-on-AK007-a-Siglec-10-Antagonist-Antibody-at-the-Society-for-Immu-42271595/?utm_medium=RSS&utm_content=20221110